Investor Meyer Thomas
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Meyer Thomas . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-05-06 13D/A CYTOF / Altamira Therapeutics Ltd. 22,297 1,079,843
2024-03-13 13D/A CYTOF / Altamira Therapeutics Ltd. 22,297
2023-04-27 13D/A 88,603
2023-01-18 13D/A 84,106
2022-09-13 13D/A 2QA / ALTAMIRA THERAPEUTICS LTD 1,163,639 1,677,152
2022-05-13 13D/A 2QA / ALTAMIRA THERAPEUTICS LTD 1,163,639
2021-05-21 13D/A H03579101 / Auris Medical Holding Ltd 660,525 817,263
2020-12-07 13D/A H03579101 / Auris Medical Holding Ltd 660,525 660,525
2020-10-06 13D/A H03579101 / Auris Medical Holding Ltd 532,912 660,525
2020-08-20 13D/A H03579101 / Auris Medical Holding Ltd 529,573 532,912
2019-08-12 13D/A H03579101 / Auris Medical Holding Ltd 489,573 529,573
2019-06-13 13D/A H03579101 / Auris Medical Holding Ltd 9,165,947 489,573
2018-11-21 13D/A H03579101 / Auris Medical Holding Ltd 5,869,083 9,165,947
2018-07-23 13D/A H03579101 / Auris Medical Holding Ltd 775,868 5,869,083
2018-04-03 13D H03579101 / Auris Medical Holding Ltd 7,642,500 775,868
2017-02-21 13D/A H03579101 / Auris Medical Holding Ltd 6,792,500 7,642,500
2016-06-01 13D/A H03579101 / Auris Medical Holding Ltd 6,792,500
2014-08-14 13D H03579101 / Auris Medical Holding Ltd 6,742,250